Stockreport

Melinta Therapeutics Presents Updates on the Pyrrolocytosine Compound RX-P2382 against ESKAPE Pathogens at ECCMID 2018

MELINTA THERAPEUTICS INC  (MLNT) 
Last melinta therapeutics inc earnings: 11/12 04:39 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
PDF NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing n [Read more]